LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 7.01 | 17.25 | 669 | 389 | 1.7176 | 1.2556 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 7.01 | 17.25 | 815 | 389 | 2.0924 | 1.3569 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 7.01 | 17.25 | 813 | 389 | 2.0873 | 1.3556 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 15 | 445 | 0.0337 | -0.0294 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 776 | 445 | 1.7435 | 1.2517 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 756 | 445 | 1.6986 | 1.2392 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 975 | 445 | 2.1907 | 1.3641 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 8.98 | 17.25 | 953 | 445 | 2.1412 | 1.3526 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 26 | 471 | 0.0551 | 0.0897 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 822 | 471 | 1.7431 | 1.2470 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 766 | 471 | 1.6244 | 1.2140 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 1035 | 471 | 2.1948 | 1.3581 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.95 | 17.25 | 1016 | 471 | 2.1545 | 1.3490 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.91 | 17.25 | 33 | 494 | 0.0667 | 0.1433 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.91 | 17.25 | 845 | 494 | 1.7076 | 1.2337 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 12.91 | 17.25 | 798 | 494 | 1.6126 | 1.2074 | MN20160310_N02 | D05 |